Annual Report

Overview

The report presents strong FY2015-16 consolidated performance, with total revenue of 72,400.83 lakhs and profit for the period of 10,378.34 lakhs. It highlights the development and commercial transfer of 11 oncology and 4 non-oncology APIs, alongside 18 new oncology drugs under development. The report also describes heat-pump, bipolar-membrane, and biomass-boiler initiatives for energy and resource conservation.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2015-2016
Period: 1 April 2015 – 31 March 2016
Publication date: 26 August 2016
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services